Sistemde güncelleme ve geliştirme çalışmaları devam etmektedir

Inhibition of proteasome by bortezomib increase chemosensitivity of bcr/abl positive human k562 chronic myleoid leukemia cells to imatinib

KIRIKKALE UNIVERSITY Career
Staff Login Login

Publication

Inhibition of proteasome by bortezomib increase chemosensitivity of bcr/abl positive human k562 chronic myleoid leukemia cells to imatinib

01 Ocak 2009 Makale Özgün Makale Google Scholar
Authors
DOÇENT COŞKUN ÖZTEKİN

Atıf kopyala

D. C. ÖZTEKİN (2009). Inhibition of proteasome by bortezomib increase chemosensitivity of bcr/abl positive human k562 chronic myleoid leukemia cells to imatinib. *HEALTH*, 1(4), 320–324. https://doi.org/10.4236/health.2009.14052

Yayın bilgileri

Dergi HEALTH
DOI 10.4236/health.2009.14052
Veri tabanı BioMedSearch, ICMJE Journal Listing, Open J-Gate; Google Scholar
Cilt / Sayı 1 / 4
Sayfa 320 – 324
Yayına Git

Atıf verisi 15 Kasım 2026 tarihinde güncellendi.

Dergi: HEALTH | Yıl: 2009 | Cilt/Sayı: 1/4 | Sayfa: 320-324 | DOI: 10.4236/health.2009.14052 | Yazarlar: BARAN YUSUF,ÖZTEKİN COŞKUN,BASSOY ESEN YONCA

Citations by source

Kaynak Atıf
Google Scholar 3
Etkin 0

Yayın metrikleri (GS / WoS / Scopus)

3 Google Scholar Atıf

UN Sustainable Development Goals

Goals linked to this publication

Good Health and Well-Being
AI Assistant
Online